Last: | $0.6483 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.6483 |
High: | $0 |
Low: | $0 |
Volume: | 5,426 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.6483 | $0 | $0.6483 | $0 | $0 | 5,426 | 10-16-2023 |
$0.6483 | $0.7615 | $0.6483 | $0.8 | $0.645 | 2,433,445 | 10-13-2023 |
$0.7793 | $0.7983 | $0.7793 | $0.8593 | $0.6501 | 4,508,691 | 10-12-2023 |
$0.82 | $0.7783 | $0.82 | $0.9599 | $0.77 | 11,057,297 | 10-11-2023 |
$0.752 | $0.6381 | $0.752 | $0.7836 | $0.57 | 7,474,298 | 10-10-2023 |
$0.6184 | $0.5445 | $0.6184 | $0.659 | $0.5221 | 5,673,450 | 10-09-2023 |
$0.541 | $0.518 | $0.541 | $0.586 | $0.500099 | 2,950,680 | 10-06-2023 |
$0.5402 | $0.5013 | $0.5402 | $0.5578 | $0.488 | 2,781,969 | 10-05-2023 |
$0.53 | $0.53 | $0.53 | $0.5431 | $0.4833 | 3,157,090 | 10-04-2023 |
$0.54 | $0.44 | $0.54 | $0.5944 | $0.44 | 9,287,919 | 10-03-2023 |
$0.47 | $0.49 | $0.47 | $0.49 | $0.4104 | 3,086,430 | 10-02-2023 |
$0.448 | $0.47 | $0.448 | $0.4978 | $0.4411 | 3,566,165 | 09-29-2023 |
$0.4622 | $0.5 | $0.4622 | $0.5006 | $0.4579 | 5,790,687 | 09-28-2023 |
$0.5097 | $0.4224 | $0.5097 | $0.699 | $0.42 | 53,652,369 | 09-27-2023 |
$0.4283 | $0.4036 | $0.4283 | $0.455 | $0.4 | 5,576,605 | 09-26-2023 |
$0.39 | $0.5266 | $0.39 | $0.5266 | $0.3779 | 9,332,067 | 09-25-2023 |
$0.59 | $0.6535 | $0.59 | $0.6535 | $0.585 | 2,429,019 | 09-22-2023 |
$0.6313 | $0.7 | $0.6313 | $0.7 | $0.625 | 1,683,224 | 09-21-2023 |
$0.703 | $0.7069 | $0.703 | $0.7373 | $0.7029 | 1,237,118 | 09-20-2023 |
$0.7198 | $0.6896 | $0.7198 | $0.7198 | $0.68201 | 1,273,674 | 09-19-2023 |
News, Short Squeeze, Breakout and More Instantly...
Consulting giant McKinsey & Co, on Friday, agreed to a settlement of $78 million to resolve allegations tied to the opioid epidemic, as di...
The U.S. Supreme Court is set to deliberate on the future of mifepristone, a crucial drug employed in over half of all abortions within the U.S.&nb...
The U.S. Supreme Court is reviewing a contentious bankruptcy settlement involving Purdue Pharma, the maker of OxyContin, and its owners, the&n...